Related Experiment Videos
Defective mitogen-induced cellular cytotoxicity in myelodysplastic syndromes. Recovery after alpha-interferon
G Eliopoulos1, M Constantopoulou, S Coulocheri
1Department of Hematology, University of Crete School of Medicine, University Hospital of Heraklion, Greece.
Insights
Myelodysplastic syndromes (MDS) patients show significantly reduced mitogen-induced cellular cytotoxicity (MICC). Alpha-interferon (α-IFN) therapy restored MICC levels in MDS patients, though natural killer-cell cytotoxicity (NKCC) remained impaired.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Immune dysregulation, particularly impaired cellular cytotoxicity, is implicated in MDS pathogenesis.
- Mitogen-induced cellular cytotoxicity (MICC) and natural killer-cell cytotoxicity (NKCC) are key components of cellular immunity.
Purpose of the Study:
- To investigate cellular cytotoxicity in patients with myelodysplastic syndromes (MDS).
- To assess the impact of alpha-interferon (α-IFN) therapy on cellular cytotoxicity in MDS.
- To explore correlations between cytotoxicity, lymphocyte subpopulations, and treatment response.
Main Methods:
- Assessed peripheral blood mitogen-induced cellular cytotoxicity (MICC) and natural killer-cell cytotoxicity (NKCC) using the 18-hour chromium release assay.
- Stimulated MICC cultures in vitro with phytohemagglutinin (PHA).
- Analyzed lymphocyte subpopulations (CD3+, CD4+, CD8+, CD16+) and correlated findings with cytotoxicity levels and α-IFN treatment.
Main Results:
- MDS patients exhibited significantly reduced MICC compared to controls (p < 0.001), but higher than their own NKCC (p < 0.001).
- Significant decreases were observed in CD3+, CD4+ cells, and the CD4+/CD8+ ratio in MDS patients.
- Following α-IFN therapy, MICC normalized, while NKCC remained below control levels; absolute CD3+ and CD8+ counts decreased, and CD16+ cells increased.
Conclusions:
- MDS patients demonstrate severely impaired MICC, which is potentially reversible with α-IFN treatment.
- The precise mechanisms underlying MICC dysfunction in MDS and its restoration by α-IFN require further elucidation.
- α-IFN therapy may modulate immune function in MDS, but its long-term impact on cytotoxicity and disease progression warrants additional research.
Abstract:
Peripheral blood mitogen - induced cellular cytotoxicity (MICC) and natural killer- cell cytotoxicity (NKCC) were assessed in 25 patients with myelodysplastic syndromes (MDS). Both MICC and NKCC were examined under the same experimental conditions using the 18 hr chromium release assay, except that cultures for MICC were stimulated in vitro by the addition of phytohemagglutinin (PHA). Patients' MICC was found significantly reduced, in relation to controls (p less than 0.001), but significantly higher than patients' NKCC (p less than 0.001). Furthermore, patients CD3+ cells and CD4+ cells, as well as the CD4+/CD8+ ratio, were significantly decreased (p less than 0.01, p less than 0.001 and p less than 0.001, respectively), while CD8+ cells and CD16+ cells were within normal limits. No relationship was noted between patients' MICC and total lymphocyte count or any lymphocyte subpopulation. In eleven patients who were subsequently subjected to a-interferon (a-IFN) administration, MICC values were found within normal range one month after the cessation of alpha-IFN, while NKCC values were significantly increased (p less than 0.01), but they still remained below the lower limit of the control (p less than 0.001). Percentages of CD3+, CD4+ and CD8+ cells, as well as the CD4+/CD8+ ratio, did not change after alpha-IFN, but the absolute numbers of CD3+ cells and CD8+ cells were significantly reduced. A statistically significant rise was noted in CD16+ cells. Post- IFN rises in MICC did not correlate with lymphocyte subpopulations. The findings indicate that MDS patients display very low MICC, which can be restored by alpha-IFN administration. The cause of this disturbance and the mechanism of its restoration by alpha-IFN remain unclear.